Cargando…

The Value of Neutrophil-to-Lymphocyte Ratio and Epicardial Adipose Tissue Thickness in Heart Failure With Preserved Ejection Fraction

Background Using epicardial adipose tissue thickness (EATt) and neutrophil-to-lymphocyte ratio (NLR) as individual indicators provides beneficial insight into the prognosis of patients suffering from heart failure with preserved ejection fraction (HFpEF). Aim In our study, we aimed to evaluate wheth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colluoglu, Tugce, Akın, Yeşim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395397/ https://www.ncbi.nlm.nih.gov/pubmed/37538972 http://dx.doi.org/10.7759/cureus.42846

Ejemplares similares

Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020)

Heart Failure with Preserved Ejection Fraction: Can Device Therapy Be Our Option?
por: Ahmed, Talha
Publicado: (2020)

Management of Heart Failure With Preserved Ejection Fraction in Elderly Patients: Effectiveness and Safety
por: Elkammash, Amr, et al.
Publicado: (2023)

Deciphering the Dilemma: Anticoagulation for Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Jyotsna, FNU, et al.
Publicado: (2023)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Importance of epicardial adipose tissue as a predictor of heart failure with preserved ejection fraction
por: Ateş, Kenan, et al.
Publicado: (2022)

Role of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction: A Review Article
por: Mgbemena, Okechukwu, et al.
Publicado: (2021)

Inspiratory Muscle Training in Patients With Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
por: Baral, Nischit, et al.
Publicado: (2020)

Improving risk stratification in heart failure with preserved ejection fraction by combining two validated risk scores
por: Boralkar, Kalyani Anil, et al.
Publicado: (2019)

Expression of epicardial adipose tissue thermogenic genes in patients with reduced and preserved ejection fraction heart failure
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2017)

Epicardial Adiposity in Relation to Metabolic Abnormality, Circulating Adipocyte FABP, and Preserved Ejection Fraction Heart Failure
por: Lin, Jiun-Lu, et al.
Publicado: (2021)

Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives
por: van Woerden, Gijs, et al.
Publicado: (2022)

Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Baral, Nischit, et al.
Publicado: (2021)

Neutrophil‐to‐lymphocyte ratio and outcomes in patients with new‐onset or worsening heart failure with reduced and preserved ejection fraction
por: Curran, Fraser M., et al.
Publicado: (2021)

Association of Major Depressive Disorder on Heart Failure With Reduced and Preserved Ejection Fraction: Analysis of National Readmission Database 2018
por: Thyagaturu, Harshith S, et al.
Publicado: (2021)

Epicardial Adipose Tissue and Development of Atrial Fibrillation (AFIB) and Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Zain, Sarmad, et al.
Publicado: (2023)

Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2018)

Isolated Flailed P3 Scallop of the Mitral Valve Leaflet in the Setting of Newly Diagnosed Heart Failure With Preserved Ejection Fraction
por: Salas Noain, Jesus, et al.
Publicado: (2020)

High Neutrophil to Lymphocyte Ratio and Its Gene Signatures Correlate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction
por: Bai, Bo, et al.
Publicado: (2021)

Correction to: ‘Neutrophil‐to‐lymphocyte ratio and outcomes in patients with new‐onset or worsening heart failure with reduced and preserved ejection fraction’
Publicado: (2023)

QRS duration and cardiovascular mortality in Asian patients with heart failure and preserved and reduced ejection fraction
por: Yap, Jonathan, et al.
Publicado: (2021)

Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF)
por: Parikh, Riya R, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction update: A review of clinical trials and new therapeutic considerations
por: Maryniak, Andrii, et al.
Publicado: (2022)

Physician Variability in Diastology Reporting in Patients With Preserved Ejection Fraction: A Single Center Experience
por: Patel, Raj, et al.
Publicado: (2020)

Lead aVR is a predictor for mortality in heart failure with preserved ejection fraction
por: İçen, Yahya Kemal, et al.
Publicado: (2018)

Do we need a definition of acute heart failure with preserved ejection fraction?
por: Kapłon-Cieślicka, Agnieszka, et al.
Publicado: (2021)

Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes
por: Salvatore, Teresa, et al.
Publicado: (2022)

Global Longitudinal Strain as an Efficient Prognostic Tool in Hypertrophic Cardiomyopathy With Preserved Left Ventricular Ejection Fraction
por: Battel, Owen, et al.
Publicado: (2022)

Prevalence and prognostic value of monoclonal gammopathy in heart failure patients with preserved ejection fraction: A prospective study
por: Devesa, Ana, et al.
Publicado: (2022)

Epicardial Fat Thickness: A Cardiometabolic Risk Marker in Rheumatoid Arthritis
por: Saha, Sekhar, et al.
Publicado: (2022)

The Relation of Epicardial Fat Thickness, Neutrophil to Lymphocyte Ratio and Circadian Rhythm of Blood Pressure
por: Choi, Jae Hyuk
Publicado: (2016)

Epicardial Fat Thickness and Neutrophil to Lymphocyte Ratio are Increased in Non-Dipper Hypertensive Patients
por: Kim, Bong Joon, et al.
Publicado: (2016)

Epicardial Fat in Heart Failure with Preserved Ejection Fraction: Bad Actor or Just Lying Around?
por: Oduah, Mary-Tiffany, et al.
Publicado: (2023)

Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus
por: Shi, Yu-Jiao, et al.
Publicado: (2023)

The Effect of Sacubitril-Valsartan on Ventricular Arrhythmia Burden in Patients With Heart Failure With Reduced Ejection Fraction
por: Medeiros, Paulo, et al.
Publicado: (2023)

The Role of Prognostic Nutrition Index in Predicting Hospitalization of Patients With Heart Failure With Mildly Reduced Ejection Fraction
por: Yurdam, Ferhat S, et al.
Publicado: (2022)

Proteomic profiling of epicardial fat in heart failure with preserved versus reduced and mildly reduced ejection fraction
por: Gao, Qian, et al.
Publicado: (2023)

Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Obesity, epicardial adipose tissue and left atrial cardiomyopathy in patients with heart failure with preserved ejection fraction: a cardiac MRI based study
por: Lobeek, M, et al.
Publicado: (2023)

Neutrophil-to-lymphocyte ratio as a possible indicator of epicardial adipose tissue in patients undergoing hemodialysis
por: Ozcicek, Adalet, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7iql9udbsok90c6a6rs70jk952